ZNF438
gene geneOn this page
Also known as bA330O11.1
Summary
ZNF438 (zinc finger protein 438, HGNC:21029) is a protein-coding gene on chromosome 10p11.23, encoding Zinc finger protein 438 (Q7Z4V0). Isoform 1 acts as a transcriptional repressor.
Enables DNA-binding transcription factor activity. Involved in negative regulation of DNA-templated transcription. Located in cytosol and nucleoplasm.
Source: NCBI Gene 220929 — RefSeq curated summary.
At a glance
- GWAS associations: 17
- Clinical variants (ClinVar): 141 total
- MANE Select transcript:
NM_001143768
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:21029 |
| Approved symbol | ZNF438 |
| Name | zinc finger protein 438 |
| Location | 10p11.23 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | bA330O11.1 |
| Ensembl gene | ENSG00000183621 |
| Ensembl biotype | protein_coding |
| OMIM | 620749 |
| Entrez | 220929 |
Gene structure
Transcript identifiers
Ensembl transcripts: 43 — 42 protein_coding, 1 nonsense_mediated_decay
ENST00000331737, ENST00000361310, ENST00000375311, ENST00000413025, ENST00000436087, ENST00000442986, ENST00000452305, ENST00000538351, ENST00000609683, ENST00000885964, ENST00000885965, ENST00000885966, ENST00000885967, ENST00000885968, ENST00000885969, ENST00000885970, ENST00000885971, ENST00000885972, ENST00000885973, ENST00000885974, ENST00000885975, ENST00000885976, ENST00000885977, ENST00000885978, ENST00000885979, ENST00000885980, ENST00000885981, ENST00000916165, ENST00000916166, ENST00000945872, ENST00000945873, ENST00000945874, ENST00000945875, ENST00000945876, ENST00000945877, ENST00000945878, ENST00000945879, ENST00000945880, ENST00000945881, ENST00000945882, ENST00000945883, ENST00000945884, ENST00000945885
RefSeq mRNA: 10 — MANE Select: NM_001143768
NM_001143766, NM_001143767, NM_001143768, NM_001143769, NM_001143770, NM_001143771, NM_001387405, NM_001387411, NM_001387412, NM_182755
CCDS: CCDS44369, CCDS53504, CCDS7168
Canonical transcript exons
ENST00000436087 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001365983 | 30941575 | 30941651 |
| ENSE00001380125 | 30908933 | 30909015 |
| ENSE00001524163 | 30984369 | 30984426 |
| ENSE00003474084 | 30848531 | 30850367 |
| ENSE00003487529 | 30876998 | 30877065 |
| ENSE00003967280 | 31031833 | 31031865 |
| ENSE00003967281 | 30844632 | 30845573 |
Expression profiles
Bgee: expression breadth ubiquitous, 209 present calls, max score 91.70.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 10.8337 / max 336.0323, expressed in 1641 samples.
FANTOM5 promoters (9 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 108959 | 4.7874 | 1521 |
| 108957 | 3.4761 | 448 |
| 108956 | 1.2543 | 263 |
| 108960 | 0.4402 | 225 |
| 108961 | 0.3295 | 154 |
| 108955 | 0.2943 | 111 |
| 108958 | 0.1986 | 52 |
| 108949 | 0.0353 | 8 |
| 108950 | 0.0180 | 7 |
Top tissues by expression
238 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| tibialis anterior | UBERON:0001385 | 91.70 | silver quality |
| monocyte | CL:0000576 | 90.41 | gold quality |
| deltoid | UBERON:0001476 | 89.99 | silver quality |
| leukocyte | CL:0000738 | 89.70 | gold quality |
| calcaneal tendon | UBERON:0003701 | 88.78 | gold quality |
| tendon | UBERON:0000043 | 87.93 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 87.89 | gold quality |
| gastrocnemius | UBERON:0001388 | 87.80 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 87.65 | gold quality |
| muscle of leg | UBERON:0001383 | 87.38 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 87.27 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 86.56 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 86.52 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 86.33 | gold quality |
| secondary oocyte | CL:0000655 | 85.87 | gold quality |
| oocyte | CL:0000023 | 85.46 | gold quality |
| saphenous vein | UBERON:0007318 | 85.23 | gold quality |
| layer of synovial tissue | UBERON:0007616 | 85.23 | gold quality |
| blood | UBERON:0000178 | 85.08 | gold quality |
| apex of heart | UBERON:0002098 | 84.59 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 84.35 | gold quality |
| muscle tissue | UBERON:0002385 | 84.17 | gold quality |
| biceps brachii | UBERON:0001507 | 83.75 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 83.70 | gold quality |
| granulocyte | CL:0000094 | 83.63 | gold quality |
| quadriceps femoris | UBERON:0001377 | 83.13 | silver quality |
| pancreatic ductal cell | CL:0002079 | 83.09 | silver quality |
| ascending aorta | UBERON:0001496 | 82.78 | gold quality |
| thoracic aorta | UBERON:0001515 | 82.73 | gold quality |
| ventricular zone | UBERON:0003053 | 82.49 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.67 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
22 targeting ZNF438, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-3658 | 99.96 | 73.87 | 4379 |
| HSA-MIR-548AA | 99.96 | 70.64 | 3753 |
| HSA-MIR-548AP-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548T-3P | 99.96 | 70.64 | 3753 |
| HSA-LET-7C-3P | 99.95 | 73.42 | 2862 |
| HSA-MIR-498-3P | 99.91 | 71.27 | 1114 |
| HSA-MIR-4420 | 99.82 | 70.08 | 1624 |
| HSA-MIR-181B-2-3P | 99.81 | 70.06 | 1646 |
| HSA-MIR-181B-3P | 99.81 | 70.06 | 1646 |
| HSA-MIR-448 | 99.79 | 72.37 | 2103 |
| HSA-MIR-4766-5P | 99.75 | 69.23 | 2662 |
| HSA-MIR-217-5P | 99.49 | 69.93 | 1419 |
| HSA-MIR-513A-3P | 99.39 | 70.63 | 3620 |
| HSA-MIR-513C-3P | 99.39 | 70.63 | 3620 |
| HSA-MIR-4999-5P | 99.35 | 69.15 | 926 |
| HSA-MIR-6807-3P | 99.15 | 69.23 | 1275 |
| HSA-MIR-3606-3P | 99.11 | 69.84 | 3254 |
| HSA-MIR-4477A | 98.83 | 69.75 | 2952 |
| HSA-MIR-6761-5P | 98.71 | 68.03 | 1504 |
| HSA-MIR-4778-5P | 97.96 | 68.06 | 1634 |
| HSA-MIR-27B-5P | 97.34 | 66.55 | 549 |
Literature-anchored findings (GeneRIF, showing 1)
- The transcriptional activity of ZNF438 was studied by transfecting recombinant pM-ZNF438 into mammalian cells. The subsequent analysis based on the duel luciferase assay system showed that ZNF438 was a transcriptional repressor. (PMID:17669267)
Cross-species orthologs
7 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | znf438 | ENSDARG00000061311 |
| mus_musculus | Zfp438 | ENSMUSG00000050945 |
| rattus_norvegicus | Zfp438 | ENSRNOG00000028329 |
| caenorhabditis_elegans | WBGENE00005008 | |
| caenorhabditis_elegans | WBGENE00006827 | |
| caenorhabditis_elegans | WBGENE00011924 | |
| caenorhabditis_elegans | WBGENE00011925 |
Paralogs (2): ZBTB4 (ENSG00000174282), ZBTB38 (ENSG00000177311)
Protein
Protein identifiers
Zinc finger protein 438 — Q7Z4V0 (reviewed: Q7Z4V0)
All UniProt accessions (3): Q7Z4V0, Q5T427, V9GYJ1
UniProt curated annotations — full annotation on UniProt →
Function. Isoform 1 acts as a transcriptional repressor.
Subcellular location. Nucleus.
Tissue specificity. Ubiquitous.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q7Z4V0-1 | 1 | yes |
| Q7Z4V0-2 | 2 | |
| Q7Z4V0-3 | 3 |
RefSeq proteins (10): NP_001137238, NP_001137239, NP_001137240, NP_001137241, NP_001137242, NP_001137243, NP_001374334, NP_001374340, NP_001374341, NP_877432 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
UniProt features (18 total): zinc finger region 4, region of interest 4, compositionally biased region 3, sequence variant 3, splice variant 2, chain 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q7Z4V0-F1 | 49.71 | 0.03 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 58 (showing top):
ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN, KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3, MARSON_BOUND_BY_E2F4_UNSTIMULATED, chr10p11, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOBP_NEGATIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_METABOLIC_PROCESS, DELACROIX_RARG_BOUND_MEF, DELACROIX_RAR_BOUND_ES, GSE13522_WT_VS_IFNAR_KO_SKING_T_CRUZI_Y_STRAIN_INF_DN, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, CBX7_TARGET_GENES, NAB2_TARGET_GENES, TFEB_TARGET_GENES, ZNF10_TARGET_GENES, ZNF22_TARGET_GENES
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), negative regulation of DNA-templated transcription (GO:0045892)
GO Molecular Function (7): DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), DNA-binding transcription factor activity (GO:0003700), zinc ion binding (GO:0008270), sequence-specific DNA binding (GO:0043565), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (3): nucleus (GO:0005634), nucleoplasm (GO:0005654), cytosol (GO:0005829)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 3 |
| cellular anatomical structure | 2 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| negative regulation of RNA biosynthetic process | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transcription cis-regulatory region binding | 1 |
| transcription regulator activity | 1 |
| transition metal ion binding | 1 |
| DNA binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| nuclear lumen | 1 |
| cytoplasm | 1 |
Protein interactions and networks
STRING
550 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF438 | ZNF780A | O75290 | 567 |
| ZNF438 | ZNF546 | Q86UE3 | 552 |
| ZNF438 | ZNF780B | Q9Y6R6 | 535 |
| ZNF438 | ZNF827 | Q17R98 | 491 |
| ZNF438 | GARIN6 | Q8NEG0 | 480 |
| ZNF438 | IKZF2 | Q9UKS7 | 425 |
| ZNF438 | ZSCAN16 | Q9H4T2 | 423 |
| ZNF438 | TSGA10IP | Q3SY00 | 419 |
| ZNF438 | ZNF695 | Q8IW36 | 409 |
| ZNF438 | ZKSCAN8 | Q15776 | 408 |
| ZNF438 | ZNF132 | P52740 | 407 |
| ZNF438 | NKAPL | Q5M9Q1 | 406 |
| ZNF438 | ZNF668 | Q96K58 | 403 |
| ZNF438 | ZNF165 | P49910 | 397 |
| ZNF438 | ZNF10 | P21506 | 392 |
IntAct
206 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SYT17 | ZNF438 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GOLGA6L9 | ZNF438 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF438 | ZBTB8A | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF438 | SSX2IP | psi-mi:“MI:0915”(physical association) | 0.560 |
| GOLGA2 | ZNF438 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF438 | ZNF526 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF438 | PICK1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RABEP1 | ZNF438 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FXR1 | ZNF438 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF438 | TSGA10 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF438 | BACH2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SET | ZNF438 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT40 | ZNF438 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MCC | ZNF438 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TP53BP2 | ZNF438 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF438 | MID2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF438 | MDFI | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF143 | ZNF438 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF438 | BANP | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRAF2 | ZNF438 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MTUS2 | ZNF438 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF438 | ZNF629 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF438 | KCTD7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| YES1 | ZNF438 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF438 | SCNM1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF438 | TBC1D22B | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF17 | ZNF438 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF438 | PRMT7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PLEKHN1 | ZNF438 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (76): ZNF438 (Two-hybrid), ZNF438 (Two-hybrid), ZNF438 (Two-hybrid), ZNF438 (Two-hybrid), ZNF438 (Two-hybrid), ZNF438 (Two-hybrid), ZNF438 (Two-hybrid), ZNF438 (Two-hybrid), ZNF438 (Two-hybrid), ZNF438 (Two-hybrid), ZNF438 (Two-hybrid), ZNF438 (Two-hybrid), ZNF438 (Two-hybrid), ZNF438 (Two-hybrid), ZNF438 (Two-hybrid)
ESM2 similar proteins: A0A0A6YY25, A0A5K7RLP0, A6NMK8, A8MVX0, B2RQL2, B2RXH4, C9JSJ3, D2J0Y4, O54824, P97303, Q01954, Q05AH6, Q0VET5, Q14005, Q1W617, Q2YDE2, Q3MHT3, Q3U0P1, Q3ULM6, Q3UXL4, Q4R7L6, Q5RC05, Q5T0L3, Q68CR7, Q6GQV1, Q6NS69, Q6NZK5, Q6P1D7, Q6PG16, Q6ZVT6, Q7Z4V0, Q80W88, Q80XI1, Q811R2, Q86T90, Q86YN6, Q8BHP2, Q8BLK9, Q8BP99, Q8BW86
Diamond homologs: A0A1V6NWD3, B0ZT45, F9XMW5, J9VX63, O75362, P53243, P56270, P56670, P56671, P78871, Q00453, Q01800, Q02027, Q12132, Q14119, Q4WXK4, Q5RC05, Q7Z4V0, Q9US36, Q9UTS5, S8AKF3, W3X9K7, P60319, Q01611, Q8SW43, Q92618, Q9NUA8, B0X9H6, E9PZZ1, F1QQA8, G5EBU4, O15090, O60315, O62836, O95125, P08048, P17010, P17012, P28166, P31509
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
141 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 116 |
| Likely benign | 15 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2121 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 10:30876993:CTTA:C | donor_loss | 1.0000 |
| 10:30876996:A:AC | donor_gain | 1.0000 |
| 10:30876997:C:CA | donor_loss | 1.0000 |
| 10:30876997:C:CC | donor_gain | 1.0000 |
| 10:30877061:CTTTC:C | acceptor_gain | 1.0000 |
| 10:30877064:TCC:T | acceptor_loss | 1.0000 |
| 10:30877066:C:CC | acceptor_gain | 1.0000 |
| 10:30877067:T:A | acceptor_loss | 1.0000 |
| 10:30877072:A:AC | acceptor_gain | 1.0000 |
| 10:30877072:A:C | acceptor_gain | 1.0000 |
| 10:30884766:TG:T | donor_gain | 1.0000 |
| 10:30908928:AATAC:A | donor_loss | 1.0000 |
| 10:30908929:ATACC:A | donor_loss | 1.0000 |
| 10:30908932:CCT:C | donor_loss | 1.0000 |
| 10:30908932:CCTT:C | donor_gain | 1.0000 |
| 10:30909011:CATAC:C | acceptor_gain | 1.0000 |
| 10:30909013:TAC:T | acceptor_gain | 1.0000 |
| 10:30909014:ACC:A | acceptor_loss | 1.0000 |
| 10:30909015:CCTAA:C | acceptor_loss | 1.0000 |
| 10:30909016:CTA:C | acceptor_loss | 1.0000 |
| 10:30970906:C:CT | donor_gain | 1.0000 |
| 10:30970907:T:TT | donor_gain | 1.0000 |
| 10:30876991:AACTT:A | donor_loss | 0.9900 |
| 10:30876992:ACTT:A | donor_loss | 0.9900 |
| 10:30876997:CCTT:C | donor_gain | 0.9900 |
| 10:30877062:TTTC:T | acceptor_gain | 0.9900 |
| 10:30877063:TTC:T | acceptor_gain | 0.9900 |
| 10:30877064:TC:T | acceptor_gain | 0.9900 |
| 10:30877065:CC:C | acceptor_gain | 0.9900 |
| 10:30877077:C:CT | acceptor_gain | 0.9900 |
AlphaMissense
5461 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 10:30848677:A:C | F576L | 0.996 |
| 10:30848677:A:T | F576L | 0.996 |
| 10:30848679:A:G | F576L | 0.996 |
| 10:30848648:A:G | L586P | 0.994 |
| 10:30848690:C:T | C572Y | 0.993 |
| 10:30848857:G:C | F516L | 0.993 |
| 10:30848857:G:T | F516L | 0.993 |
| 10:30848859:A:G | F516L | 0.993 |
| 10:30848689:A:C | C572W | 0.992 |
| 10:30848650:A:C | H585Q | 0.991 |
| 10:30848650:A:T | H585Q | 0.991 |
| 10:30848652:G:C | H585D | 0.990 |
| 10:30848661:A:C | Y582D | 0.990 |
| 10:30848691:A:G | C572R | 0.990 |
| 10:30848746:G:C | H553Q | 0.990 |
| 10:30848746:G:T | H553Q | 0.990 |
| 10:30848787:A:G | C540R | 0.990 |
| 10:30848796:A:G | C537R | 0.990 |
| 10:30848693:A:G | F571S | 0.989 |
| 10:30848830:G:C | H525Q | 0.989 |
| 10:30848830:G:T | H525Q | 0.989 |
| 10:30848630:A:T | V592D | 0.988 |
| 10:30848700:A:G | C569R | 0.988 |
| 10:30848858:A:G | F516S | 0.988 |
| 10:30848699:C:T | C569Y | 0.987 |
| 10:30848786:C:T | C540Y | 0.987 |
| 10:30848840:A:G | L522P | 0.987 |
| 10:30848880:A:G | C509R | 0.987 |
| 10:30845503:A:G | C649R | 0.986 |
| 10:30848637:G:C | H590D | 0.986 |
dbSNP variants (sampled 300 via entrez): RS1000016380 (10:30957567 G>A), RS1000027223 (10:30913939 A>C), RS1000029425 (10:30935713 A>T), RS1000058684 (10:31001425 G>A,C), RS1000073792 (10:31018373 C>A,T), RS1000078574 (10:30879426 C>A,T), RS1000112791 (10:30988070 A>G), RS1000121183 (10:30977459 T>C), RS1000153721 (10:31012496 AAT>A), RS1000158216 (10:31030198 C>T), RS1000185622 (10:30970565 G>A), RS1000191509 (10:30892196 T>C,G), RS1000201724 (10:31024848 A>T), RS1000203688 (10:30983617 A>G), RS1000227411 (10:30937471 T>C)
Disease associations
OMIM: gene MIM:620749 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
17 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001198_87 | Multiple sclerosis | 3.000000e-06 |
| GCST002318_167 | Rheumatoid arthritis | 6.000000e-07 |
| GCST002318_37 | Rheumatoid arthritis | 1.000000e-09 |
| GCST002574_1 | Congenital left-sided heart lesions (maternal effect) | 6.000000e-07 |
| GCST002702_22 | Height | 7.000000e-08 |
| GCST003488_17 | Response to fenofibrate (triglyceride levels) | 2.000000e-06 |
| GCST006959_111 | Rheumatoid arthritis | 2.000000e-07 |
| GCST006959_90 | Rheumatoid arthritis | 8.000000e-06 |
| GCST006979_574 | Heel bone mineral density | 1.000000e-12 |
| GCST007096_195 | Pulse pressure | 1.000000e-08 |
| GCST007097_17 | Pulse pressure | 1.000000e-07 |
| GCST007097_18 | Pulse pressure | 5.000000e-07 |
| GCST008839_473 | Height | 4.000000e-15 |
| GCST009597_233 | Multiple sclerosis | 3.000000e-19 |
| GCST010059_5 | Physiological traits | 6.000000e-06 |
| GCST010703_265 | Brain morphology (MOSTest) | 4.000000e-13 |
| GCST90000025_397 | Appendicular lean mass | 3.000000e-09 |
EFO canonical traits (6, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005939 | parental genotype effect measurement |
| EFO:0007681 | triglyceride change measurement |
| EFO:0009270 | heel bone mineral density |
| EFO:0005763 | pulse pressure measurement |
| EFO:0004346 | neuroimaging measurement |
| EFO:0004980 | appendicular lean mass |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
28 total (human), top 28 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Cadmium Chloride | increases expression, decreases expression | 3 |
| Benzo(a)pyrene | increases methylation, affects methylation, decreases expression | 2 |
| aristolochic acid I | decreases expression | 1 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| pirinixic acid | affects binding, decreases expression, increases activity | 1 |
| kojic acid | increases expression | 1 |
| sodium arsenite | increases expression | 1 |
| cobaltous chloride | decreases expression | 1 |
| potassium chromate(VI) | affects cotreatment, decreases expression | 1 |
| epigallocatechin gallate | affects cotreatment, decreases expression | 1 |
| cylindrospermopsin | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| abrine | increases expression | 1 |
| jinfukang | affects cotreatment, decreases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Cisplatin | affects cotreatment, decreases expression | 1 |
| Dexamethasone | increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Melphalan | decreases expression | 1 |
| Methotrexate | increases expression | 1 |
| Dronabinol | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Valproic Acid | decreases methylation, increases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Copper Sulfate | increases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_XW47 | HEK293 eGFP-ZNF438 | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): congenital left-sided heart lesions